Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hk Inno.n Corporation

Clinical trials sponsored by Hk Inno.n Corporation, explained in plain language.

HK inno.N Corporation 195940 KOSDAQ

A pharmaceutical company developing and commercializing drugs and healthcare products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 5

New GERD drug tegoprazan tested in large real-world study

Disease control Recruiting now

This study investigates the safety and symptom-relieving effects of the drug Tegoprazan (K-CAB) in adults with gastroesophageal reflux disease (GERD). Researchers will track how well the drug reduces heartburn and acid reflux after 4 weeks of use. The study includes over 5,000 pa…

Sponsor: HK inno.N Corporation • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC